Transmissible gastroenteritis is a highly contagious viral disease of swine caused by the transmissible gastroenteritis virus, a coronavirus that produces severe diarrhea and vomiting, particularly devastating to neonatal piglets. This disease has been recognized in pig populations worldwide since its first description in the United States during the 1940s and remains an important cause of piglet mortality in susceptible herds. The virus infects the intestinal epithelium, destroying the absorptive cells essential for nutrient uptake and resulting in profuse watery diarrhea, rapid dehydration, and high mortality in young pigs lacking maternal immunity.
Transmissible gastroenteritis affects pigs of all ages but clinical severity varies dramatically with age at infection. Piglets infected during the first week of life experience mortality rates approaching one hundred percent without intervention, while pigs infected after three weeks of age typically recover with minimal lasting effects. Adult pigs generally show only mild clinical signs or remain subclinically infected while shedding large quantities of virus that perpetuate transmission within herds. This age-dependent susceptibility pattern profoundly influences outbreak dynamics and control strategies in breeding herds where protecting neonatal piglets represents the primary objective.
The economic impact of transmissible gastroenteritis varies according to herd immune status and time of virus introduction relative to farrowing. In naive breeding herds experiencing initial outbreak, virtually all piglets born during the epidemic period may succumb to the disease, representing catastrophic losses. Endemic herds with established immunity typically experience sporadic disease primarily affecting litters from gilts lacking adequate passive immunity. Beyond direct mortality losses, economic impacts include reduced weaning weights in surviving piglets, increased labor and treatment costs during outbreaks, and potential sow reproductive effects from the stress and inappetence accompanying clinical disease.
Management of transmissible gastroenteritis focuses on prevention through biosecurity, establishment of herd immunity, and supportive care during outbreaks since no specific antiviral treatment exists. Understanding the epidemiology, clinical presentation, and control options enables producers and veterinarians to implement effective strategies that minimize losses in affected herds while preventing introduction into disease-free populations. The close relationship between transmissible gastroenteritis virus and porcine respiratory coronavirus has important implications for diagnosis and immunity that must be considered in disease management programs.
